Navigation Links
Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards
Date:10/25/2012

PLANTATION, Fla., Oct. 25, 2012 /PRNewswire/ -- Goodwin Biotechnology, Inc. (GBI) has been named a three-category winner in the 2012 CMO Leadership Awards presented by Life Science Leader magazine. GBI was rated in the top 20% for Innovation, Productivity and Regulatory.

"We at GBI are honored to be recognized in three categories of the CMO Leadership Awards, and consider it a testament to the quality of our people and their dedication to our customers," noted Bansi K. Bhan, Interim CEO at Goodwin Biotechnology, Inc.  "Regarding innovation, our scientists take great pride in identifying and implementing solutions to the most complex challenges. We are also proud of the Productivity award because we have established a history of meeting and exceeding our clients' expectations by consistently delivering on agreed upon objectives. Further, from a regulatory perspective, we focus on both quality and compliance as a single source for biologics development and manufacturing from cell line engineering and proof of concept through to cGMP manufacturing of late-stage clinical trial material."

Life Science Leader developed the annual CMO Leadership Awards in 2011 to honor top outsourcing industry performers based on leading research to better serve pharmaceutical and biopharmaceutical executives in the CMO vetting process. Life Science Leader partnered with the professional marketing research agency, Nice Insight, who created a methodology that combines the surveying of thousands of industry executives with other key analyses, such as review of marketing material, to facilitate better overall outsourcing collaborations.

Nice Insight is moving into its third year of conducting primary research on the outsourcing practices of pharmaceutical and biotechnology executives. For the 2012 CMO Leadership Awards survey, the sample size was over 10,000 executives who provided their perceptions on 170 contract manufacturing organizations (CMOs). The companies that service the drug development cycle were rated on six key drivers in outsourcing – Quality, Reliability, Productivity, Regulatory, Affordability, and Innovation. Leadership Award winners scored in the top 20% of all CMOs in each of the previously mentioned categories.

"At Life Science Leader, we think that data-driven awards are more objective and valuable than recognizing companies as a result of a nomination and voting process," shared Rob Wright, Editor in Chief, Life Science Leader. "The core of the research is focused on awareness, or how well a CMO and its service offering are known within the outsourcing industry, and customer perceptions, or how the business is regarded by the potential and current buyers of outsourced services.  The winners should be proud of these awards because they were determined by the perceptions of their target audiences."

About Goodwin Biotechnology, Inc.

Goodwin Biotechnology is a world-class CMO that offers fully integrated cGMP contract manufacturer of monoclonal antibodies, recombinant proteins and vaccines. GBI has the expertise and experience in cell line development, proof of concept, process development and GMP manufacturing of recombinant proteins and antibodies, as well as conjugated therapeutic proteins (e.g., antibodies conjugated to linkers for radioimmune therapy and diagnostics, other antibodies, proteins, chemotoxins, or plant toxins) by leveraging our proprietary conjugation technology. By working with GBI, our clients can enhance the value of their product candidates with clear development and manufacturing strategies and a road map to meet the highest quality product requirements from the milligram and gram range to kilogram quantities as the product candidates move along the clinical approval pathway in a cost-effective, timely and cGMP compliant manner to enhanced patients' lives. With 20 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies of all sizes from small university spin-offs to major research institutes, government agencies and large, established biopharmaceutical companies.

For more information, please contact:

Goodwin Biotechnology:
Dave Cunningham
Director of Marketing & Administration
(954) 327-9639
DCunningham@goodwinbio.com


'/>"/>
SOURCE Goodwin Biotechnology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Agricultural Biotechnology: Emerging Technologies and Global Markets
2. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
3. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
4. Antibiotics and Biotechnology Take Center Stage at Food Dialogues Event
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
9. Archbishop Desmond Tutu and the International Childrens Peace Prize Winners Launch Remember2015
10. Elsevier and Australasian Research Management Society Announce Winners of the 2012 Scopus Young Researcher of the Year Awards
11. Winner Medical Reports Third Quarter Fiscal 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... India , Jan. 24, 2017 Market Research Future has ... Market for Wound Closure Device is growing rapidly and expected to continue ... ... at a CAGR of 5% from 2013 to 2019 and reaching a ... of the forecasted period, 2016-2022 Global Wound Closure Device Market ...
(Date:1/24/2017)... Nev. , Jan. 24, 2017  The ... that specializes in high-value orthopaedic implants, announced the ... today. The OIC Tibial Nail ... tibia. Strategically placed proximal and distal screw holes ... hole that allows dynamization.  The nail is available ...
(Date:1/24/2017)... 2017 Trifecta Clinical , a leading ... Rick Ward to Vice President of Commercial ... also announcing the promotion of Ericka Atkinson ... Rick joins Trifecta from Greenphire where he was ... business development positions within the healthcare industry throughout his ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... ... to Thrive , Well-meaning studies such as the Fordham Institute’s High Stakes ... serve top students, such as including gifted or high-achieving students as a subgroup ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... Pollack, Ph.D., http://www.faculty.washington.edu/ghp , Sharon Kleyne, the nation’s foremost water advocate ... Global Climate Change and Your Health on Voice America, once again welcomed one ...
(Date:1/24/2017)... ... ... A yellow fever outbreak in Brazil has infected over 100 people and claimed ... contact with infected mosquitos. The outbreak has sparked increased concern about the virus and ... multiple health organizations, the best way to prevent yellow fever is through vaccination. For ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... topics like finances, friendship, marriage, leadership, gossip, prostitution, adultery, anger, and common sense. ... authors, Dr. Judith Coats and Dr. David Coats. In September of 1983, they ...
(Date:1/24/2017)... ... , ... “Mysteries Revealed On Speaking In Tongues”: an engaging and dynamic ... Christians. “Mysteries Revealed On Speaking In Tongues” is the creation of published author, Tina ... located in Michigan. , “We need to partner with Jesus and be the ...
Breaking Medicine News(10 mins):